Buprenorphine Pharmacology Related to Addiction Treatment - 21

National Institutes of Health (NIH)

Status and phase: Completed; Phase 2

Conditions: Opioid-Related Disorders

Treatments: Drug: Buprenorphine

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00000239

NIDA-06969-21

R01-06969-21

Details and patient eligibility

About

The purpose of this study is to examine if chronic buprenorphine administration will generate supersensitivity to opiates.

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.